Back to DYN
MARSHALL WACE, LLP DYN Position History
Dyne Therapeutics, Inc. • Healthcare
Quarters held
16
Latest value
$18.6M
Q2 2026
Peak value
$38.1M
First seen
Q1 2023
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2023 | $156K |
| Q1 2023 | $1.4M |
| Q2 2023 | $248K |
| Q3 2023 | $198K |
| Q1 2024 | $1.5M |
| Q2 2024 | $9.7M |
| Q4 2024 | $464K |
| Q4 2024 | $113K |
| Q2 2025 | $4.3M |
| Q3 2025 | $38.1M |
| Q4 2025 | $718K |
| Q4 2025 | $3.6M |
| Q4 2025 | $9M |
| Q2 2026 | $1.1M |
| Q2 2026 | $13.4M |
| Q2 2026 | $18.6M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $18.6M | 835.7K | — | — |
| Q2 2026 | $13.4M | 605.2K | — | — |
| Q2 2026 | $1.1M | 48.0K | — | — |
| Q4 2025 | $9M | 458.7K | — | — |
| Q4 2025 | $3.6M | 181.5K | — | — |
| Q4 2025 | $718K | 36.7K | — | — |
| Q3 2025 | $38.1M | 3.01M | — | — |
| Q2 2025 | $4.3M | 447.8K | — | — |
| Q4 2024 | $113K | 4.8K | — | — |
| Q4 2024 | $464K | 19.7K | — | — |
| Q2 2024 | $9.7M | 273.6K | — | — |
| Q1 2024 | $1.5M | 53.7K | — | — |
| Q3 2023 | $198K | 22.1K | — | — |
| Q2 2023 | $248K | 22.1K | — | — |
| Q1 2023 | $1.4M | 118.8K | — | — |
| Q1 2023 | $156K | 13.5K | — | — |
Other funds holding DYN
$165.6M
$165.6M
$120.6M
$118.5M
$41.6M